Bilal Arif - Dec 31, 2022 Form 3 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Tech Ops Officer
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Bilal Arif
Stock symbol
SRPT
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
3
Date filed
1/4/2023, 07:01 PM
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SRPT Common Stock 22.9K Dec 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SRPT Stock Option (right to buy) Dec 31, 2022 Common Stock 8.3K $119.19 Direct F1
holding SRPT Stock Option (right to buy) Dec 31, 2022 Common Stock 4.8K $114.47 Direct F1
holding SRPT Stock Option (right to buy) Dec 31, 2022 Common Stock 4.2K $114.47 Direct F1
holding SRPT Stock Option (right to buy) Dec 31, 2022 Common Stock 4.95K $87.11 Direct F1
holding SRPT Stock Option (right to buy) Dec 31, 2022 Common Stock 5K $87.11 Direct F1
holding SRPT Stock Option (right to buy) Dec 31, 2022 Common Stock 8.4K $80.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.